Search
for
Sort by
Research 211–240 of 334
- Spectrum of Phenotypes Associated with Human MC1R Variations
- Fgf21 Deficiency Delays Hair Follicle Cycling and Modulates miRNA–Target Gene Interactions in Mice
- Hair & Cutaneous Development
- Unraveling the Molecular Mechanism of Bider Marking Formation in Dun Mongolian Horses Through Transcriptome Sequencing
- A Short Report on Melanocyte/Melanoma Culture, Senescence, and Reproducibility
- Research Progress on Construction Technology of 3D Human Skin Models and Its Application Prospects in Dermatology
- Stress-induced sympathetic hyperactivation drives hair follicle necrosis to trigger autoimmunity
- Multi-omics analysis unveils the role of cancer-associated fibroblasts in cutaneous squamous cell carcinoma
- Involvement of hair follicles in skin tumorigenesis, skin homeostasis and wound healing
- Autophagy Dysfunction: The Kernel of Hair Loss?
- Research advances of tissue-derived extracellular vesicles in cancers
- Toward a Unifying Hypothesis for Redesigned Lipid Catabolism as a Clinical Target in Advanced, Treatment-Resistant Carcinomas
- Synthetic Approaches for Pharmacologically Active Decorated Six-Membered Diazines
- Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients
- Pre‐clinical evidences for the efficacy of tryptanthrin as a potent suppressor of skin cancer
- Three Streams for the Mechanism of Hair Graying
- Human Hair Graying Revisited: Principles, Misconceptions, and Key Research Frontiers
- Exosomes: A Promising Strategy for Repair, Regeneration and Treatment of Skin Disorders
- Vitamin A resolves lineage plasticity to orchestrate stem cell lineage choices
- Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma
- Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
- Network pharmacology and molecular docking analysis on potential molecular targets and mechanism of action of BRAF inhibitors for application in wound healing
- The risk of dermatological toxicities of combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma patients: a systematic review and meta-analysis
- Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects
- Melanotic pigmentation in excisional scar of melanoma patient who received BRAF and MEK inhibitors
- 554 Repurposing a clinical antimalarial for the therapeutic induction of lethal ER stress targeting BRAF-kinase inhibitor-resistant malignant melanoma
- 696 MEK and BRAF inhibitors augment the production and accumulation of sebum in hamster sebocytes
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- Cutaneous toxicities of new treatments for melanoma
- The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B‐rapidly accelerated fibrosarcoma‐mutated advanced melanoma